Bilim VN - Search Results

1

GSK-3 inhibition in vitro and in vivo enhances antitumor effect of sorafenib in renal cell carcinoma (RCC).

Kawazoe H, Bilim VN, Ugolkov AV, Yuuki K, Naito S, Nagaoka A, Kato T, Tomita Y. Kawazoe H, et al. Among authors: bilim vn. Biochem Biophys Res Commun. 2012 Jul 6;423(3):490-5. doi: 10.1016/j.bbrc.2012.05.147. Epub 2012 Jun 5. Biochem Biophys Res Commun. 2012. PMID: 22683636

2

Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53.

Tomita Y, Bilim V, Kawasaki T, Takahashi K, Okan I, Magnusson KP, Wiman KG. Tomita Y, et al. Int J Cancer. 1996 May 3;66(3):322-5. doi: 10.1002/(SICI)1097-0215(19960503)66:3<322::AID-IJC9>3.0.CO;2-0. Int J Cancer. 1996. PMID: 8621251

3

Tetrapeptide DEVD-aldehyde or YVAD-chloromethylketone inhibits Fas/Apo-1(CD95)-mediated apoptosis in renal-cell-cancer cells.

Tomita Y, Kawasaki T, Bilim V, Takeda M, Takahashi K. Tomita Y, et al. Int J Cancer. 1996 Sep 27;68(1):132-5. doi: 10.1002/(SICI)1097-0215(19960927)68:1<132::AID-IJC23>3.0.CO;2-C. Int J Cancer. 1996. PMID: 8895553

4

Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations.

Kawasaki T, Tomita Y, Bilim V, Takeda M, Takahashi K, Kumanishi T. Kawasaki T, et al. Int J Cancer. 1996 Nov 15;68(4):501-5. doi: 10.1002/(SICI)1097-0215(19961115)68:4<501::AID-IJC16>3.0.CO;2-7. Int J Cancer. 1996. PMID: 8945622

5

Variable Bcl-2 phenotype in benign and malignant lesions of urothelium.

Bilim VN, Tomita Y, Kawasaki T, Takeda M, Takahashi K. Bilim VN, et al. Cancer Lett. 1998 Jun 5;128(1):87-92. doi: 10.1016/s0304-3835(98)00055-x. Cancer Lett. 1998. PMID: 9652797

6

Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC).

Bilim VN, Kawasaki T, Takahashi K, Tomita Y. Bilim VN, et al. Anticancer Res. 1998 May-Jun;18(3A):1655-9. Anticancer Res. 1998. PMID: 9673385

7

Infrequent alteration of p53 pathway in metastatic renal cell carcinoma.

Kawasaki T, Bilim V, Takahashi K, Tomita Y. Kawasaki T, et al. Oncol Rep. 1999 Mar-Apr;6(2):329-33. doi: 10.3892/or.6.2.329. Oncol Rep. 1999. PMID: 10022999

8

Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.

Bilim V, Kawasaki T, Katagiri A, Wakatsuki S, Takahashi K, Tomita Y. Bilim V, et al. Clin Cancer Res. 2000 Feb;6(2):460-6. Clin Cancer Res. 2000. PMID: 10690524

9

Caspase involved synergistic cytotoxicity of bcl-2 antisense oligonucleotides and adriamycin on transitional cell cancer cells.

Bilim V, Kasahara T, Noboru H, Takahashi K, Tomita Y. Bilim V, et al. Cancer Lett. 2000 Jul 31;155(2):191-8. doi: 10.1016/s0304-3835(00)00428-6. Cancer Lett. 2000. PMID: 10822135

10

Adriamycin induced G2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes.

Bilim V, Kawasaki T, Takahashi K, Tomita Y. Bilim V, et al. J Exp Clin Cancer Res. 2000 Dec;19(4):483-8. J Exp Clin Cancer Res. 2000. PMID: 11277327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters